Evolution and spread of antibiotic resistance
暂无分享,去创建一个
[1] M. Caparon,et al. Excision and insertion of the conjugative transposon Tn916 involves a novel recombination mechanism , 1989, Cell.
[2] T. Grundström,et al. Isolation and characterization of DNA repetitions carrying the chromosomal beta-lactamase gene of Escherichia coli K-12. , 1979, Molecular & general genetics : MGG.
[3] S. Lindquist,et al. Genetic basis of induction and overproduction of chromosomal class I beta-lactamase in nonfastidious gram-negative bacilli. , 1988, Reviews of infectious diseases.
[4] S. Normark. beta-Lactamase induction in gram-negative bacteria is intimately linked to peptidoglycan recycling. , 1995, Microbial drug resistance.
[5] N. Brown,et al. Transposition in prokaryotes: transposon Tn501. , 1991, Research in microbiology.
[6] H. Nikaido. Preventing drug access to targets: cell surface permeability barriers and active efflux in bacteria. , 2001, Seminars in cell & developmental biology.
[7] P. H. Roy,et al. Transposon Tn5090 of plasmid R751, which carries an integron, is related to Tn7, Mu, and the retroelements , 1994, Journal of bacteriology.
[8] J. Mekalanos,et al. In vivo expression technology for selection of bacterial genes specifically induced in host tissues. , 1994, Methods in enzymology.
[9] D. Andersson,et al. Biological cost and compensatory evolution in fusidic acid‐resistant Staphylococcus aureus , 2001, Molecular microbiology.
[10] F. Taddei,et al. High Frequency of Mutator Strains among Human Uropathogenic Escherichia coli Isolates , 2002, Journal of bacteriology.
[11] Hiroshi Nikaido,et al. Multidrug resistance mechanisms: drug efflux across two membranes , 2000, Molecular microbiology.
[12] T. Grundström,et al. The E. coli beta-lactamase attenuator mediates growth rate-dependent regulation. , 1981, Nature.
[13] A. Tomasz,et al. Mechanism of action of penicillin: triggering of the pneumococcal autolytic enzyme by inhibitors of cell wall synthesis. , 1975, Proceedings of the National Academy of Sciences of the United States of America.
[14] T. Grundström,et al. Sequence elements determining ampC promoter strength in E. coli. , 1982, The EMBO journal.
[15] Claude Carbón,et al. Complex relationship between acquisition of beta-lactam resistance and loss of virulence in Streptococcus pneumoniae. , 2001, The Journal of infectious diseases.
[16] S. Normark,et al. Common mechanism of ampC beta-lactamase induction in enterobacteria: regulation of the cloned Enterobacter cloacae P99 beta-lactamase gene , 1987, Journal of bacteriology.
[17] F. Baquero. Resistance to quinolones in gram-negative microorganisms: mechanisms and prevention. , 1990, European urology.
[18] P. Bradford. Extended-Spectrum β-Lactamases in the 21st Century: Characterization, Epidemiology, and Detection of This Important Resistance Threat , 2001, Clinical Microbiology Reviews.
[19] Kim Rutherford,et al. Complete genome sequence of a multiple drug resistant Salmonella enterica serovar Typhi CT18 , 2001, Nature.
[20] F. Tenover,et al. A global gene pool for high-level cephalosporin resistance in commensal Streptococcus species and Streptococcus pneumoniae. , 1997, The Journal of infectious diseases.
[21] L. Gutmann,et al. Acquisition of Five High-MrPenicillin-Binding Protein Variants during Transfer of High-Level β-Lactam Resistance from Streptococcus mitis toStreptococcus pneumoniae , 1998, Journal of bacteriology.
[22] S. Lindquist,et al. Signalling proteins in enterobacterial AmpC beta-lactamase regulation. , 1989, Molecular microbiology.
[23] N. Gotoh,et al. Characterization of MexE–MexF–OprN, a positively regulated multidrug efflux system of Pseudomonas aeruginosa , 1997, Molecular microbiology.
[24] R. Bonomo,et al. SHV-type beta-lactamases. , 1999, Current pharmaceutical design.
[25] R. Gómez-Lus,et al. Evolution of bacterial resistance to antibiotics during the last three decades. , 1998, International microbiology : the official journal of the Spanish Society for Microbiology.
[26] J. Musser,et al. Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update. , 1998, Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[27] J. Shapiro,et al. Transposition of a beta-lactamase locus from RP1 into Pseudomonas putida degradative plasmids , 1977, Journal of bacteriology.
[28] N. Datta,et al. Mutant Drug Resistant Factors of High Transmissibility , 1967, Nature.
[29] P. White,et al. Integrons and Gene Cassettes in theEnterobacteriaceae , 2001, Antimicrobial Agents and Chemotherapy.
[30] D. Alland,et al. Molecular determinants of drug resistance in tuberculosis. , 2000, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[31] W. Reznikoff,et al. Tn5/IS50 target recognition. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[32] H. H. Martin,et al. AmpG, a signal transducer in chromosomal beta-lactamase induction. , 1993, Molecular microbiology.
[33] B. Wretlind,et al. Alterations in GyrA and ParC Associated with Fluoroquinolone Resistance in Enterococcus faecium , 1999, Antimicrobial Agents and Chemotherapy.
[34] B. Spratt,et al. Multiply antibiotic-resistant Streptococcus pneumoniae recovered from Spanish hospitals (1988-1994): novel major clones of serotypes 14, 19F and 15F. , 1996, Microbiology.
[35] R. Hancock,et al. Negative Regulation of the Pseudomonas aeruginosa Outer Membrane Porin OprD Selective for Imipenem and Basic Amino Acids , 1999, Antimicrobial Agents and Chemotherapy.
[36] J. Frère,et al. Cytosolic Intermediates for Cell Wall Biosynthesis and Degradation Control Inducible β-Lactam Resistance in Gram-Negative Bacteria , 1997, Cell.
[37] T. Köhler,et al. C-Terminal Region of Pseudomonas aeruginosa Outer Membrane Porin OprD Modulates Susceptibility to Meropenem , 2001, Antimicrobial Agents and Chemotherapy.
[38] Manuel Peitsch,et al. A genome-based approach for the identification of essential bacterial genes , 1998, Nature Biotechnology.
[39] M. Galleni,et al. Signalling proteins in enterobacterial AmpC β‐lactamase regulation , 1989 .
[40] S. Normark,et al. Purification and mutant analysis of Citrobacter freundii AmpR, the regulator for chromosomal AmpC β‐lactamase , 1991, Molecular microbiology.
[41] T. Grundström,et al. Isolation and characterization of DNA repetitions carrying the chromosomal β-lactamase gene of Escherichia coli K-12 , 1979, Molecular and General Genetics MGG.
[42] P. H. Roy,et al. Oligonucleotide probes for the detection of TEM-1 and TEM-2 beta-lactamase genes and their transposons. , 1987, Canadian journal of microbiology.
[43] S. Normark,et al. Emergence of vancomycin tolerance in Streptococcus pneumoniae , 1999, Nature.
[44] L Sundström,et al. The Potential of Integrons and Connected Programmed Rearrangements for Mediating Horizontal Gene Transfer , 1998, APMIS. Supplementum.
[45] T. Marrie,et al. Molecular epidemiology of Streptococcus pneumoniae causing invasive disease in 5 countries. , 2000, The Journal of infectious diseases.
[46] N. Høiby,et al. Rapid emergence of resistance in Pseudomonas aeruginosa in cystic fibrosis patients due to in-vivo selection of stable partially derepressed beta-lactamase producing strains. , 1990, The Journal of antimicrobial chemotherapy.
[47] Nanne Nanninga,et al. Morphogenesis of Escherichia coli , 1998, Microbiology and Molecular Biology Reviews.
[48] H. Nikaido,et al. High-Level Fluoroquinolone-Resistant Clinical Isolates of Escherichia coli Overproduce Multidrug Efflux Protein AcrA , 2000, Antimicrobial Agents and Chemotherapy.
[49] Angela Lee,et al. Identification and Characterization of Inhibitors of Multidrug Resistance Efflux Pumps in Pseudomonas aeruginosa: Novel Agents for Combination Therapy , 2001, Antimicrobial Agents and Chemotherapy.
[50] K. Poole,et al. Multidrug efflux pumps and antimicrobial resistance in Pseudomonas aeruginosa and related organisms. , 2001, Journal of molecular microbiology and biotechnology.
[51] G. Chiosis,et al. Selective Cleavage of D-Ala-D-Lac by Small Molecules: Re-Sensitizing Resistant Bacteria to Vancomycin , 2001, Science.
[52] S. Szu,et al. Covalent linkage between the capsular polysaccharide and the cell wall peptidoglycan of Streptococcus pneumoniae revealed by immunochemical methods. , 1990, Microbial pathogenesis.
[53] W. L. Payne,et al. High Mutation Frequencies Among Escherichia coli and Salmonella Pathogens , 1996, Science.
[54] N. Datta,et al. Transposition of a deoxyribonucleic acid sequence encoding trimethoprim and streptomycin resistances from R483 to other replicons , 1976, Journal of bacteriology.
[55] P. Sansonetti,et al. Microbes and Microbial Toxins : Paradigms for Microbial-Mucosal Interactions III . Shigellosis : from symptoms to molecular pathogenesis , 2001 .
[56] J. Tobias,et al. Antibiotic-based selection for bacterial genes that are specifically induced during infection of a host. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[57] O. Sköld,et al. Genetic analyses of sulfonamide resistance and its dissemination in gram-negative bacteria illustrate new aspects of R plasmid evolution , 1991, Antimicrobial Agents and Chemotherapy.
[58] R. Hall,et al. Transposons Tn1696 and Tn21and Their Integrons In4 and In2 Have Independent Origins , 2001, Antimicrobial Agents and Chemotherapy.
[59] H. H. Martin,et al. AmpG, a signal transducer in chromosomal β‐lactamase induction , 1993 .
[60] Jorge E. Galán,et al. Structural mimicry in bacterial virulence , 2001, Nature.
[61] B. Spratt,et al. Interspecies recombination between the penA genes of Neisseria meningitidis and commensal Neisseria species during the emergence of penicillin resistance in N. meningitidis: natural events and laboratory simulation , 1994, Journal of bacteriology.
[62] N. Hanson,et al. Regulation of inducible AmpC beta-lactamase expression among Enterobacteriaceae. , 1999, Current pharmaceutical design.
[63] J. Zhou,et al. Dynamics of penicillin-susceptible clones in invasive pneumococcal disease. , 2001, The Journal of infectious diseases.
[64] A. Ortqvist,et al. Changes in serotype distribution may hamper efficacy of pneumococcal conjugate vaccines in children. , 2001, Scandinavian journal of infectious diseases.
[65] T. Grundström,et al. The E. coli β-lactamase attenuator mediates growth rate-dependent regulation , 1981, Nature.
[66] B. Neville,et al. HYPERFLEXION CERVICAL CORD INJURY IN A CHILDREN'S CAR SEAT , 1981, The Lancet.
[67] M. Jacobs,et al. Single- and multi-step resistance selection study of gemifloxacin compared with trovafloxacin, ciprofloxacin, gatifloxacin and moxifloxacin in Streptococcus pneumoniae. , 2001, The Journal of antimicrobial chemotherapy.
[68] K. Lewis,et al. Biofilms and Planktonic Cells of Pseudomonas aeruginosa Have Similar Resistance to Killing by Antimicrobials , 2001, Journal of bacteriology.
[69] S. Lindquist,et al. Inactivation of the ampD gene causes semiconstitutive overproduction of the inducible Citrobacter freundii beta-lactamase , 1987, Journal of bacteriology.
[70] S. Normark,et al. Insertion of IS2 creates a novel ampC promoter in Escherichia coli , 1983, Cell.
[71] Martin C. J. Maiden,et al. Database-driven Multi Locus Sequence Typing (MLST) of bacterial pathogens , 2001, Bioinform..
[72] K. Drlica,et al. Fluoroquinolone-resistant Streptococcus pneumoniae associated with levofloxacin therapy. , 2001, The Journal of infectious diseases.
[73] D. Andersson,et al. Virulence of antibiotic-resistant Salmonella typhimurium. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[74] J. Lupski. Molecular mechanisms for transposition of drug-resistance genes and other movable genetic elements. , 1987, Reviews of infectious diseases.
[75] S. Normark,et al. Regulatory components in Citrobacter freundii ampC beta-lactamase induction. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[76] Ian Phillips,et al. &bgr;-LACTAMASE-PRODUCING, PENICILLIN-RESISTANT GONOCOCCUS , 1976, The Lancet.
[77] H. Nikaido,et al. Role of mexA-mexB-oprM in antibiotic efflux in Pseudomonas aeruginosa , 1995, Antimicrobial agents and chemotherapy.
[78] S. Hultgren,et al. Establishment of a Persistent Escherichia coli Reservoir during the Acute Phase of a Bladder Infection , 2001, Infection and Immunity.
[79] A. Tomasz,et al. The murMN operon: A functional link between antibiotic resistance and antibiotic tolerance in Streptococcus pneumoniae , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[80] Teruyo Ito,et al. A New Class of Genetic Element, Staphylococcus Cassette Chromosome mec, Encodes Methicillin Resistance in Staphylococcus aureus , 2000, Antimicrobial Agents and Chemotherapy.
[81] B. Levin,et al. The biological cost of antibiotic resistance. , 1999, Current opinion in microbiology.
[82] O. Berg,et al. Mutation frequency and biological cost of antibiotic resistance in Helicobacter pylori , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[83] O. Sköld. Resistance to trimethoprim and sulfonamides. , 2001, Veterinary research.
[84] George A. Jacoby,et al. Plasmid-Determined AmpC-Type β-Lactamases , 2002, Antimicrobial Agents and Chemotherapy.
[85] S. Normark,et al. Identification of a novel ampC beta‐lactamase promoter in a clinical isolate of Escherichia coli. , 1982, The EMBO journal.
[86] R. Hancock,et al. Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and impact on treatment. , 2000, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.
[87] H. Nikaido. Crossing the envelope: how cephalosporins reach their targets. , 2000, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[88] S. Normark,et al. Clinical isolates of Streptococcus pneumoniae that exhibit tolerance of vancomycin. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[89] J. Frère,et al. AmpD, essential for both β‐lactamase regulation and cell wall recycling, is a novel cytosolic N‐acetylmuramyl‐L‐alanine amidase , 1995, Molecular microbiology.
[90] J. Williams,et al. Letter: Penicillinase production by Haemophilus influenzae. , 1974, Lancet.
[91] M. Zasloff. Antimicrobial peptides of multicellular organisms , 2002, Nature.
[92] A. Tomasz. From penicillin-binding proteins to the lysis and death of bacteria: a 1979 view. , 1979, Reviews of infectious diseases.
[93] K. Poole,et al. MexR Repressor of the mexAB-oprMMultidrug Efflux Operon of Pseudomonas aeruginosa: Identification of MexR Binding Sites in the mexA-mexRIntergenic Region , 2001, Journal of bacteriology.
[94] U. Hentschel,et al. Bacterial infection as assessed by in vivo gene expression. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[95] P. Sansonetti. III. Shigellosis: from symptoms to molecular pathogenesis , 2001 .
[96] Roger E. Bumgarner,et al. Gene expression in Pseudomonas aeruginosa biofilms , 2001, Nature.
[97] M. Tsuda,et al. Characterization of the MexC-MexD-OprJ Multidrug Efflux System in ΔmexA-mexB-oprM Mutants of Pseudomonas aeruginosa , 1998, Antimicrobial Agents and Chemotherapy.
[98] O. Berg,et al. Effects of environment on compensatory mutations to ameliorate costs of antibiotic resistance. , 2000, Science.
[99] S. Normark,et al. Bacterial cell wall recycling provides cytosolic muropeptides as effectors for beta‐lactamase induction. , 1994, The EMBO journal.
[100] A. Tomasz,et al. An acquired and a native penicillin-binding protein cooperate in building the cell wall of drug-resistant staphylococci , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[101] E. Charpentier,et al. Mechanisms of antibiotic resistance and tolerance in Streptococcus pneumoniae. , 2000, Microbes and infection.
[102] B. Jennett,et al. SURGICAL TRAINING , 1975, The Lancet.
[103] A. Tomasz,et al. Inhibition of the expression of penicillin resistance in Streptococcus pneumoniae by inactivation of cell wall muropeptide branching genes. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[104] R. Novick,et al. Penicillinase plasmids of Staphylococcus aureus: restriction-deletion maps. , 1979, Plasmid.
[105] B. Petrini,et al. Drug-resistant and multidrug-resistant tubercle bacilli. , 1999, International journal of antimicrobial agents.
[106] B. Spratt,et al. Interspecies recombinational events during the evolution of altered PBP 2x genes in penicillin‐resistant clinical isolates of Streptococcus pneumoniae , 1991, Molecular microbiology.
[107] E. Charpentier,et al. Signal transduction by a death signal peptide: uncovering the mechanism of bacterial killing by penicillin. , 2000, Molecular cell.
[108] R M Hall,et al. Site‐specific insertion of genes into integrons: role of the 59‐base element and determination of the recombination cross‐over point , 1991, Molecular microbiology.
[109] N. Høiby,et al. Molecular Mechanisms of Fluoroquinolone Resistance in Pseudomonas aeruginosa Isolates from Cystic Fibrosis Patients , 2000, Antimicrobial Agents and Chemotherapy.
[110] B W Glickman,et al. Escherichia coli mutator mutants deficient in methylation-instructed DNA mismatch correction. , 1980, Proceedings of the National Academy of Sciences of the United States of America.
[111] L. Rice,et al. Genetic Linkage and Cotransfer of a Novel,vanB-Containing Transposon (Tn5382) and a Low-Affinity Penicillin-Binding Protein 5 Gene in a Clinical Vancomycin-Resistant Enterococcus faecium Isolate , 1998, Journal of bacteriology.
[112] N. Gotoh,et al. Rapid identification of mutations in a multidrug efflux pump in Pseudomonas aeruginosa , 1999, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.
[113] K. Poole,et al. Overexpression of the mexC–mexD–oprJ efflux operon in nfxB‐type multidrug‐resistant strains of Pseudomonas aeruginosa , 1996, Molecular microbiology.